Here is a step-by-step guide on how to delete your data from #23AndMe before #Regeneron gets its hands on it.

https://www.eff.org/deeplinks/2025/03/how-delete-your-23andme-data

This is your most valuable and person data, protecting yourself against it being used by a for-profit pharmaceutical company is a good idea.

How to Delete Your 23andMe Data

This week, the genetic testing company 23andMe filed for bankruptcy, which means the genetic data the company collected on millions of users is now up for sale. If you don't want your data included in any potential sale, it’s a good time to ask the company to delete it.

Electronic Frontier Foundation

How to delete your 23andMe data

if you previously agreed to 23andMe and third-party researchers using your genetic data and sample for research, you can withdraw consent from the Research and Product Consents section in your account settings.

#Regeneron #BigPharma #23andMe #DNA #genetics #business #bankruptcy #infosec #data #bigdata #privacy #biotech

https://techcrunch.com/2025/06/11/23andme-files-for-bankruptcy-how-to-delete-your-data/

How to delete your 23andMe data | TechCrunch

23andMe holds millions of customers' genetic information. Here's what you can do to protect your data.

TechCrunch

Dozens of states sue to block the sale of 23andMe personal genetic data

Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks the court's approval to buy the struggling firm.

#Regeneron #BigPharma #23andMe #DNA #genetics #business #bankruptcy #infosec #data #bigdata #privacy #biotech

https://www.npr.org/2025/06/10/nx-s1-5429041/23andme-states-lawsuit-genetic-data

Dozens of states sue to block the sale of 23andMe personal genetic data

Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks the court's approval to buy the struggling firm.

#Regeneron #BigPharma #23andMe #DNA #genetics #business #bankruptcy #infosec #data #bigdata #privacy #biotech

https://www.npr.org/2025/06/10/nx-s1-5429041/23andme-states-lawsuit-genetic-data

23andMe and its user data will soon belong to a pharmaceutical giant

the purchase will further the company’s “large-scale genetics research” into future drugs and treatments.

#Regeneron #BigPharma #23andMe #DNA #genetics #business #bankruptcy #infosec #data #bigdata #privacy #biotech

https://www.theverge.com/news/669548/23andme-bankruptcy-auction-regeneron-purchase

23andMe and its user data will soon belong to a pharmaceutical giant

23andMe will continue to offer customers its DNA testing services after being bought out of bankruptcy by Regeneroon for $256 million.

The Verge

Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million

Regeneron is buying 23andMe’s Personal Genome Service, Total Health and Research Services business lines

#Regeneron #BigPharma #23andMe #DNA #genetics #business #bankruptcy #infosec #data #bigdata #privacy #biotech

https://www.cnbc.com/2025/05/19/regeneron-pharmaceuticals-to-buy-23andme-for-256-million-including-data.html

Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million

Regeneron is acquiring "substantially all" of 23andMe's assets for $256 million following a bankruptcy auction.

CNBC
#23andMe Sale Shows Your #Genetic Data Is Worth $17
23andMe sold genetic data of 15M people for $256M to a #pharmaceutical #Regeneron. 23andMe does not perform full genome sequences. It instead does #DNA #genotyping, which look at parts of #genome that vary from person to person.
Sale to Regeneron means #gene data collected by 23andMe will be used for development of new #drugs, which felt like the most likely and perhaps best-case scenario for the company’s bankruptcy.
https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/
23andMe Sale Shows Your Genetic Data Is Worth $17

23andMe sold the genetic data of 15 million people for $256 million to a pharmaceutical company called Regeneron.

404 Media

🧬 Breaking: Regeneron acquires 23andMe's assets for $256M, including genome and research services—but not Lemonaid Health. Deal awaits court approval amid privacy safeguards.

#23andMe #Regeneron #Biotech

#Biotech company #Regeneron to buy bankrupt #23andMe for $256M

Regeneron assured 23andMe's 15 million customers that their data—including #genetic and health information, #genealogy , and other sensitive personal information—would be safe and in good hands. Regeneron aims to use the large trove of genetic data to further its own work using genetics to develop medical advances—something 23andMe tried and failed to do.
#privacy #tos

https://arstechnica.com/science/2025/05/biotech-company-regeneron-to-buy-bankrupt-23andme-for-256m/

Biotech company Regeneron to buy bankrupt 23andMe for $256M

Regeneron will use trove of 23andMe genetic data to develop medical advances.

Ars Technica

#23andMe Sale Shows Your #Genetic Data Is Worth $17

#Regeneron is a drug company that “intends to acquire 23andMe’s Personal #Genome Service (PGS), Total Health and Research Services business lines, together with its #Biobank and associated assets, for $256 million and for 23andMe to continue all consumer genome services uninterrupted,”
#privacy #dna #genetics

https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/

23andMe Sale Shows Your Genetic Data Is Worth $17

23andMe sold the genetic data of 15 million people for $256 million to a pharmaceutical company called Regeneron.

404 Media